Abstract
The introduction of routine reporting of eGFR is now part of the health landscape in Australia and many countries worldwide. There are well known limitations to this process and it is appropriate to keep working to address these issues. Some areas of new activity include the development of a new formula, the CKD-EPI formula; consideration of common reference intervals for serum creatinine; estimation of GFR for drug monitoring purposes and racial effects. To date there has also been little co-ordinated progress for the paediatric population with regard to creatinine measurement, reference intervals and GFR estimation. The joint working party of the Royal College of Pathologists of Australasia, the Australasian Association of Clinical Biochemists (AACB) and Kidney Health Australia plans to address these issues during 2010.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
